BATS BZX Real-Time Price
As of 3:43pm ET
| +0.20 / +7.58%|
The 4 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 7.00 and a low estimate of 6.00. The median estimate represents a +111.27% increase from the last price of 2.84.
The current consensus among 4 polled investment analysts is to Buy stock in Catalyst Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.